IOSP vs BCPC

For growth investors, Balchem Corporation (BCPC) is the stronger pick with 8.

8% revenue growth year-over-year, versus -3. 7% for Innospec Inc. (IOSP). Innospec Inc. (IOSP) offers the better valuation at 16. 6x trailing P/E (15. 7x forward), making it the more compelling value choice. Analysts rate Balchem Corporation (BCPC) a "Buy" — based on 10 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Innospec Inc.

(IOSP) is the cheapest at 16. 6x versus Balchem Corporation at 34. 0x. On forward P/E, Innospec Inc. is actually cheaper at 15. 7x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Innospec Inc. wins at 0. 49x versus Balchem Corporation's 2. 44x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

Over the past 5 years, Balchem Corporation (BCPC) delivered a total return of +24.

4%, compared to -17. 5% for Innospec Inc. (IOSP). Over 10 years, the gap is even starker: BCPC returned +162. 8% versus IOSP's +83. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Balchem Corporation (BCPC) is the lower-risk stock at 0.

33β versus Innospec Inc. 's 0. 70β — meaning IOSP is approximately 111% more volatile than BCPC relative to the S&P 500. On balance sheet safety, Innospec Inc. (IOSP) carries a lower debt/equity ratio of 6% versus 15% for Balchem Corporation — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Balchem Corporation (BCPC) is pulling ahead at 8.

8% versus -3. 7% for Innospec Inc. (IOSP). On earnings-per-share growth, the picture is similar: Innospec Inc. grew EPS 228. 9% year-over-year, compared to 20. 9% for Balchem Corporation. Over a 3-year CAGR, BCPC leads at 3. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Balchem Corporation (BCPC) is the more profitable company, earning 14.

9% net margin versus 6. 6% for Innospec Inc. — meaning it keeps 14. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BCPC leads at 21. 1% versus 8. 8% for IOSP. At the gross margin level — before operating expenses — BCPC leads at 35. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Innospec Inc. (IOSP) is the more undervalued stock at a PEG of 0. 49x versus Balchem Corporation's 2. 44x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Innospec Inc. (IOSP) trades at 15. 7x forward P/E versus 31. 2x for Balchem Corporation — 15. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for IOSP: 48. 1% to $115. 00.

All stocks in this comparison pay dividends.

Innospec Inc. (IOSP) offers the highest yield at 2. 2%, versus 0. 5% for Balchem Corporation (BCPC).

For long-horizon retirement investors, Balchem Corporation (BCPC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

33), 0. 5% yield, +162. 8% 10Y return). Both have compounded well over 10 years (BCPC: +162. 8%, IOSP: +83. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: IOSP is a small-cap deep-value stock; BCPC is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.